IRIS
FEDERICO, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.054
NA - Nord America 7.121
AS - Asia 1.336
SA - Sud America 63
AF - Africa 17
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.612
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.062
IE - Irlanda 2.400
IT - Italia 1.456
UA - Ucraina 1.267
GB - Regno Unito 961
SG - Singapore 445
DE - Germania 421
CN - Cina 414
FR - Francia 394
SE - Svezia 373
FI - Finlandia 336
GR - Grecia 255
TR - Turchia 253
KR - Corea 67
VN - Vietnam 55
BR - Brasile 45
PL - Polonia 41
NL - Olanda 34
IN - India 33
BE - Belgio 30
RU - Federazione Russa 26
CA - Canada 25
MX - Messico 25
AU - Australia 17
IR - Iran 16
ES - Italia 15
JP - Giappone 15
PK - Pakistan 13
AT - Austria 12
CZ - Repubblica Ceca 10
EG - Egitto 8
AR - Argentina 6
EC - Ecuador 6
MK - Macedonia 6
ID - Indonesia 5
DO - Repubblica Dominicana 4
HK - Hong Kong 4
RO - Romania 4
ET - Etiopia 3
EU - Europa 3
KZ - Kazakistan 3
NO - Norvegia 3
PE - Perù 3
TW - Taiwan 3
CH - Svizzera 2
DK - Danimarca 2
LT - Lituania 2
MY - Malesia 2
NG - Nigeria 2
TH - Thailandia 2
A1 - Anonimo 1
AM - Armenia 1
BD - Bangladesh 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
MO - Macao, regione amministrativa speciale della Cina 1
PR - Porto Rico 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 16.612
Salva come PNG Salva come JPEG
Città #
Dublin 2.396
Jacksonville 1.918
Chandler 1.229
Princeton 378
Roxbury 311
Singapore 236
Ann Arbor 225
Cambridge 220
Boardman 205
Medford 169
Naples 159
Wilmington 159
Beijing 147
Woodbridge 137
New York 130
Caserta 89
Des Moines 87
San Mateo 78
Houston 77
Mountain View 66
Nanjing 64
Bremen 61
Ashburn 54
Dong Ket 54
Rome 49
Seoul 47
Napoli 40
Düsseldorf 39
Kraków 33
Brussels 30
Norwalk 28
Shenyang 27
Jinan 26
Milan 26
Potenza 25
Auburn Hills 21
Boydton 19
Helsinki 18
Paris 18
Amsterdam 17
Los Angeles 16
Aversa 14
Nanchang 14
Sennori 14
Bari 13
Bologna 12
Redwood City 11
Salerno 11
Changsha 10
Jinju 10
Kunming 10
Munich 10
Palermo 10
Venice 10
Catania 9
Fairfield 9
Lappeenranta 9
Mexico 9
Vienna 9
Angers 8
Atella 8
Brno 8
Cattolica 8
Florence 8
Groningen 8
Hanover 8
Ottawa 8
Tianjin 8
Zhengzhou 8
Haikou 7
Hebei 7
Lanzhou 7
Pescara 7
Portici 7
Porto Alegre 7
Seregno 7
Borgomanero 6
Hyderabad 6
Lahore 6
London 6
Madrid 6
Orange 6
Shanghai 6
St Petersburg 6
São Paulo 6
Torino 6
Bacoli 5
Bovisio 5
Brighton 5
Daejeon 5
Hangzhou 5
Jiaxing 5
Lissone 5
Moscow 5
Nola 5
Quito 5
San Mango 5
Thessaloniki 5
Acerra 4
Berlin 4
Totale 9.579
Salva come PNG Salva come JPEG
Nome #
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 181
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 106
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 104
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 103
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 102
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 102
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 102
Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: the interim analysis of the ANSWER study 100
Intrafamilial spread of Helicobacter pylori infection 92
Comparsa di pancreatite acuta ed epatite autoimmune in corso di trattamento con IFN: descrizione di un caso clinico. 87
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 86
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 86
Angiografia perfusionale con mdc di 2a generazione nella valutazione della efficacia necrotica delle terapie ablative percutanee (PAT): studio prospettico vs TC spirale. 85
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 82
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 74
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 74
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 73
Chronic inflammation and oxidative stress in human carcinogenesis 72
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 72
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 72
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 71
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 70
Alteration of haemostasis in non-metastatic gastric cancer 69
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 69
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 69
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 68
The role of a probiotic (FLORTEC, Bracco S.p.A., Italy) on the plasma levels and peripheral blood mononuclear cell expression of cytokines in patients with ulcerative colitis: a pilot study. 68
Obesità androide postmenopausale: ruolo del DHEA-S, didrotestosterone libero ed SHBG. 68
A case of hepatotoxicity caused by green tea 67
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 67
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 65
Crohn’s disease and skin 65
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases 65
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 65
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 65
Rapporti fra alimentazione e stato nutrizionale in pazienti con cirrosi epatica. 64
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 63
The Role of Stress in Inflammatory Bowel Diseases 63
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 63
Aggregazione piastrinica in pazienti con epatite cronica da HCV: studi in vitro. 62
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 62
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 61
Sequential therapy for eradication of Helicobacter pilori infection 61
Il “pianeta” fegato grasso nella pratica clinica. Dalla Diagnosi alla terapia 61
Cause di malnutrizione nel paziente neoplastico 60
Effetti di un nuovo composto farmaceutico (Sillibina, fosfolipidi e vitamina E) sulla protezione del danno prodotto dall’alcol su cellule di adenocarcinoma gastrico MKN-28. 60
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 60
Tiroidite autoimmune in corso di trattamento con IFN in pazienti affetti da epatite cronica HCV-correlata. 60
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 60
Trace elements and chronic liver diseases 59
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 59
Chronic treatment with sylibin significantly improves insulin-resistance in patients with nonalcoholic fatty liver disease. 59
Efficacia di terapia quadruplice concomitante di cinque giorni per l’eradicazione dell’infezione dell’H. pylori in pazienti naive al trattamento. 59
Sindrome di Zollinger-Ellison associata a malattia celiaca: descrizione di un caso clinico. 59
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 59
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial 58
Le abitudini alimentari influenzano i livelli plasmatici di aminoacidi e oligoelementi nel paziente cirrotico? 58
Valutazione dell’effetto di silibina+fosfatidilcolina+vitamina E vs placebo sul danno epatico in pazienti con NAFLD (nonalcoholic fatty liver disease): risultati di un trial clinico europeo randomizzato in doppio cieco. 58
La steatoepatite non alcolica (NAFLD): studio multicentrico italiano. 58
AISF position paper on liver disease and pregnancy 58
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 57
Oligoelementi ed epatopatie: rapporti con la gravità di malattia e lo stato nutrizionale. 57
Obesità viscerale ed insulino-resistenza in corso di NASH. 56
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 56
Alcoholic hepatitis: Pathogenesis, diagnosis and treatment 56
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 55
L’utilizzo di farmaci anti-TNF nella Malattia di Crohn 55
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 55
Activated protein C resistance in nonmetastatic gastric cancer patients. 54
Effetto del trattamento cronico con sillibina sull’insulino-resistenza e sui marcatori plasmatici di fibrosi epatica in pazienti con malattia cronica di fegato. 54
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 54
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 54
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 54
Integrating Silybin and Sirtuin Related Pathways in Steatosis-Related Liver Diseases 53
Humerus metastasis from cholangiocarcinoma: a case report 53
Fibrinogeno ed acido urico quali fattori di rischio cardiovascolare in pazienti obesi. 53
Treatment of chronic hepatic encephalopathy with rifaximin. In: Encefalopatia epatica 53
Interazione tra alcol e cofattori sul rischio di cirrosi epatica. 53
Una spia sulla tavola dei nostri ragazzi 53
Alcoholic liver disease and hepatitis C chronic infection 53
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 52
Hashimoto’s thyroiditis and entero-chromaffin-like cell hyperplasia: early detection and somatostatin analogue treatment. 52
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 52
Alcohol consumption among young people in Italy: a “Facebook survey” 52
Effetti metabolici della silibina: studi in vitro e in vivo. 52
Differente risposta allo stress ossidativo fra maschi e femmine in pazienti affetti da epatite cronica da HCV. 52
Effect of Silybin in patients with chronic hepatitis: preliminary results of a multicentre randomized controlled trial vs placebo. 51
Permeabilità intestinale e malattie epatiche. 51
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 51
'' Non alcoholic fatty liver disease and eNOS dysfunction in humans '' 51
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 51
Gut microbiota and the liver 51
Gut microbiota, obesity and metabolic disorders 51
Alcohol intake and interferon therapy in patients with HCV-related chronic hepatitis. 50
Interfences of a symbiotic formulation (FB, Flortec®, Bracco s.p.a., Italy) on a gastric and intestinal permeability in rats with experimentally induced chronic liver damage. 50
Sindrome di Zollinger-Ellison associata a malattia celiaca: descrizione di un caso clinico. 50
Marcatori di perossidazione lipidica nelle malattie croniche del fegato. 50
Emostasi e cancro dello stomaco non metastatico. 50
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 50
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 50
Totale 6.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.281 0 0 0 39 335 85 397 111 113 89 87 25
2020/20212.835 225 20 321 205 374 32 392 316 39 388 364 159
2021/20222.238 95 20 27 67 784 32 54 61 88 64 204 742
2022/20234.584 448 120 49 373 454 373 17 304 2.228 44 81 93
2023/20242.095 155 69 78 151 686 169 55 58 35 68 205 366
2024/2025322 52 78 147 45 0 0 0 0 0 0 0 0
Totale 17.079